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Molecular Mechanism Induced by
Beta-Glucans from Maitake to
Recover T Cell-Subpopulations
during Immunosuppression
Aguilera Braico Diego Maximo and Balogh Gabriela Andrea
Abstract
Breast cancer is the most frequent neoplasia in the world and one of the main
causes of death among women. Some of the conventional treatments for cancer are
chemotherapy or radiotherapy, knowing that both generate very toxic side effects
since they usually affect all cells in active division (healthy or tumoral cells).
Therefore, specific treatments are necessary, with therapies aimed at the molecular
characteristics of the tumor and its microenvironment. An approach to this could be
the search for natural compounds with immunopotentiating capacity and selective
toxicity on tumor cells. Recently, immunomodulatory and antitumor activities have
been discovered in various fungi. Among them, β-glucans of D-Fraction of Grifola
frondosa (Maitake) can generate innate and adaptive immune responses, exerting
antitumor effects. The reported therapeutic benefits of treatment of breast tumor-
igenesis with D-Fraction of Maitake require to deepen pharmacological and toxico-
logical studies, in order to guarantee innocuousness and efficacy in the
administration to a patient. Therefore, this chapter aimed to elucidate toxicological,
pharmacodynamic, and pharmacokinetic aspects of β-glucans from D-Fraction.
In this way, we hope to make a significant contribution to the pharmacological
knowledge of these bioactive compounds by promoting an immunotherapeutic and
antitumor strategy novel agent.
Keywords: beta-glucans, Maitake, D-fraction, toxicological, pharmacodynamic,
pharmacokinetic studies, immunosuppression, T-cell lymphocyte
1. Introduction
Grifola frondosa, better known as Maitake, is an edible and medicinal fungus
widely known and respected in Eastern countries for thousands of years [1]. It
belongs to the Basidiomycota division,Meripilaceae family, and Polyporales order;
it grows as a parasite on the bases of deciduous and coniferous trees in forests from
Asia, Europe, and eastern North America. It has large annual basidiocarps that can
measure up to 1 m in diameter and weigh 20 kg. These are branched and formed by
numerous small fan-shaped hats, found themselves imbricated. At the nutritional
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level, fresh specimens of Grifola frondosa have 80% aqueous content, while 22–27%
dry weight corresponds to proteins, 50–60% of carbohydrates, and 4% of fats. It has
vitamins C, D, and B (B1, B2, B6), niacin, and folic acid. Among its minerals, K, P,
and Mg predominate, followed by Zn, Na, Fe, and Ca. As free sugars it has glucose,
trehalose, and mannitol. In the formation of basidiocarps, mostly malic acid was
identified, but also lactic acid, acetic, formic, citrus, succinic, oxalic, and
pyroglutamic acids. The presence of a lectin (N-acetylgalactosamine) capable of
agglutinating erythrocytes was also determined. In the early 1980s, Japanese
mycologist Hiroaki Nanba identified a fraction present in its mycelium, but also in
the fruiting body of Grifola frondosa that exhibited greater antitumor activity and
significant immunomodulatory effect [2, 3] when administered orally and intrave-
nously, which he called D-Fraction [4, 5]. Since it could be an effective immuno-
modulator orally, this characteristic made it extremely easy to administer
compared, for example, with Shiitake (lentinan) extracts, whose effect was only
optimal in intravenous administration [6]. During the 1990s, Nanba and Kubo
achieved greater purification of the D-Fraction extract, achieving the MD-Fraction,
with superior biological activity [5], highlighting the important antitumor effect of
Grifola frondosa [7–10]. D-Fraction is insoluble in acid, soluble in alkali, and
removable with hot water. Starting with Grifola frondosa, a polysaccharide formed
by a main chain of branching 1-6-D-Glucoso was placed for every three residues
of D-glucose. Glucans are polysaccharides made up exclusively of D-glucose units
bound through glycoside bonds, with the glycine being the ones with the greatest
therapeutic potential [11, 12]. The purified extract of D-Fraction has main-chain
glycogen with branches of 1,3 and the main-chain glucans of the main chain 1,3
with branches 1,6; it also has high molecular weight proteins close to
1,000,000 Da [4, 5].
Numerous fungal compounds—such as D-glucans, proteoglycans, proteins—
have been studied in recent years due to their ability to stimulate or inhibit specific
components of the immune system [13]. The immunomodulatory effects of D-
glucans on the immune system of mammals involves innate and adaptive immune
responses, being able to attribute these effects to be a polysaccharide that the body
cannot synthesize; the immune system recognizes it as triggering the innate and
adaptive immune responses [14] that contribute to the blocking of tumor progres-
sion.
Natural killer cells, which are part of innate immunity or first line of defense at
birth, are the main weapon of immunosurveillance against tumor development [1],
releasing IFN-γ, TNF-α, and GM-CSF in fulfilling its role of smoothing tumor cells.
Innate immunity is also composed of monocyte (macrophages) and neutrophils,
which, when recognizing foreign agents and put into action various enzymes such
as nitric oxide synthase (iNOS), which results in bactericidal intermediaries [13].
Macrophages secrete cytokines (IL-1, IL-6, IL-10, IL-12, TNF-α) capable of modu-
lating innate and adaptive responses, activating, in turn, other macrophages, neu-
trophils, NK, and T lymphocytes. Tumor activity in NK is enhanced by IL-2, IL-12,
and interferons [15]. T cells and NK lymphocytes produce IFN-γ that reinforces the
activation of macrophages. The innate response induced by D-Fraction β-glucans
involve activation of the protein receptor Dectin-1, which after recognizing these
polysaccharides triggers events of phagocytosis and release of cytokines [16, 17].
The extract D-Fraction of Maitake activates the macrophages to secrete IL- 1
[4, 18], IL-12 [8, 17], and TNF-α [19] and stimulates the expression of nitric oxide
synthase [20]. In addition to stimulating macrophages, IL-1 promotes the cytotox-
icity of splenic T cells, increasing their bactericidal activity [18]. Maitake can stim-
ulate NK cells both in vitro and in vivo, through the increase of IFN-γ and TNF-α in
mice [8, 21]. In addition, in macrophages IL-12 secretion associated with NK
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activation is stimulated by the increased binding to perforins in target cells,
increasing tumor lysis [8, 21]. It has been suggested that NK cells are self-activated
by the IFN-γ released by themselves [8]. Increased activation of NK was confirmed
by increased CD69 expression—NK activation marker—present on the surface of
these cells [22]. Subsequent clinical studies in cancer patients revealed that treat-
ment with D-Fraction stimulated and maintained normal activity of NK in periph-
eral blood [7]. In acquired immunity, which presents as main characteristics
specificity and memory [23], D-Fraction of Maitake decreases the expression of the
CD69 activation marker of B lymphocytes and stimulates Th lymphocytes, specifi-
cally to the Th1 lymphocytes of lymph nodes [8, 19], presenting effects on the
balance of Th1 lymphocytes/Th2 lymphocytes [19]. Carcinogenesis has been
reported to imply significant imbalance Th1L/Th2L, with a progressive decrease in
Th1L (main TLc inducers) and increased Th2L [24]. D-Fraction of Maitake can
reverse that imbalance by polarizing the ThL response to Th1L by stimulating the
secretion of IL-12 and IL-18 crucial for Th1L activation and blocking Il-1 release
important for Th2L activation [19].
2. Immune-restorative capacity of Maitake Pro4X’s beta-glucans in
immunosuppressed BALB/c females
2.1 Quantification of 1,3-beta-glucans in Maitake Pro4X
The total content of β-1,3 glucans of the purified extract of Grifola frondosa
(Maitake PRO4X) was quantified through a colorimetric method called Megazyme,
a β-glucan commercial kit (Megazyme International Ireland, Bray, Co. Wicklow,
Ireland). The samples were performed by triplicate. According to the manufac-
turer’s instructions, 0.1 μl of Exo-1,3-glucanase (20 U/ml) was added to 0.1 ml of
sample in sodium acetate buffer at 200 mM concentration and pH 5. The contents
were mixed by vortex and incubated at 40°C for 60 min. Subsequently, 3 ml of
Buffer GOPOD (glucose oxidase/peroxidase) was added and incubated for 20 min
at 40°C. The absorbance value of all samples at 510 nm was read on a Cary 50
Agilent brand UV–Vis spectrophotometer. Finally, the following equation was
applied to calculate the concentrations of 1,3-β-glucans:
β Glucan %w=wð Þ ¼ ∆E F=W 90
where.
∆E = Absorbance value of the sample at 510 nm.
F = Conversion factor = 100.
W = Sample weight (mg).
Finally, this equation was applied to refer the values with the beta-glucan stan-
dard employed in the assay.
Then, applying the formula, using the values from Table 1, the concentration of
1,3-beta-glucans from Maitake Pro4X was obtained.
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2.2 Polarity and solubility of β-glucans from Maitake Pro4X
2.2.1 Polarity of Maitake extract
Evaluation of Maitake Pro4X’s polarity by dissolving commercial samples into
solvents of increasing polarity. It was checked whether they were soluble, highly
soluble, or insoluble. The results are given in Table 2A. The results of Table 2A on
Total concentration of 1,3-b-glucans correspond to Maitake Pro4X commercial sample. The test was performed
according to the colorimetric method of the Megazyme b-Glucan kit measuring the absorbances of the samples at 510
nm. The Absorbances values indicated in the table are the corrected values referred to the blank of reagents.
Table 1.
Colorimetric quantification of beta-glucan content in Maitake Pro4X.
(A) The solubility of the commercial versions Maitake Pro4X was verified in solvents with increasing polarity. (B)
Maitake Pro4X Solubility in acidic or alkaline solvents. The results obtained were recorded as soluble, highly soluble
or insoluble.
Table 2.
Polarity/solubility of Maitake.
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polarity/solubility of purified Maitake extracts in solvents of increasing polarity
showed that both extracts were highly soluble in polar solvents and insoluble in
nonpolar solvents. This suggests hydrophilic and polar nature of that compound.
Acetone solubility, an aprotic polar solvent (without O▬H, N▬H links), was dif-
ferential for both extracts. While Maitake Pro4X proved insoluble, the standard
version was soluble. Next, to evaluation the solubility of β-glucans, a 1:4 aqueous
dilution of Maitake Pro4X was performed; an aliquot of this dilution was taken in
volume similar to the tested for Maitake Standard and dissolved in acetone, being
soluble. Dissolution in apolar solvents (n-hexane and ethyl acetate) resulted in the
formation of an insoluble upper phase of Maitake (heterogeneous system). In the
case of ethanol, both extracts generated a homogeneous system.
2.2.2 Maitake PRO4X solubility
The solubility results of Maitake Pro4X in water-soluble or fat-soluble sub-
stances, of an acidic or alkaline nature, are summarized in Table 2B. The results of
Table 2A regarding the solubility of Maitake Pro4X in solvents of acid or alkaline
character demonstrated high solubility in acidic pH (hydrochloric acid) and neutral
(distilled water) substances. Solubility was observed in bicarbonate 7.5% (m/v)
(alkaline pH), with slight ionization of the extract in the form of small whitish
precipitates. Maitake Pro4X was insoluble in fat-soluble substances (oil).
2.2.3 pH measurement of Maitake Pro4X
The acidic or alkaline nature of the purified Maitake D-Fraction Pro4X extract
from G. frondosa mushroom was determined by pH measurement at two different
temperatures (20 and 37°C) by the potentiometric method through a pH meter
Accumet (Fisher Scientific, USA), using three calibration points and accuracy of
pH 0.01. The results of pH indicated an acidic pH for Maitake Pro4X, 5.8 and 5.77,
at 20°C and 37°C, respectively. Considering the oral route of administration of beta-
glucan compound in mice, we have observed that the pH of Maitake Pro4X is
closely related to gastrointestinal organs, the duodenum and colon.
2.3 Role of 1,3-β-glucans from Maitake Pro4X in the mechanism of cell death
(apoptosis) mediated by Dectin-1 receptor activation in tumoral MCF-7
cells
2.3.1 Effect of Maitake on human tumor cells with Dectin-1 blocking
The effect of Maitake Pro4X on the feasibility and death of MCF-7 tumor cells
was investigated by mediating blocking of Dectina-1 transmembrane receptors with
Laminarin. Laminarin, 1,3-β-glucan extracted from Laminaria digitata, can specifi-
cally bind to the Dectin-1 receptor. It is considered as a Dectin-1 specific blocker.
The study indicated that Laminarin connected with ovalbumin OVA could be espe-
cially recognized by the Dectin-1 receptor expressed on dendritic cells and macro-
phage [25]. Figure 1 illustrates the mechanism of Laminarin blocking the Dectin-1
receptor through activation of certain proteins that inhibit the tumoral cell death
induced by Maitake Pro4X alone. This figure’s ideas were taken from the publica-
tion of Fesel and Zuccaro [26].
In order to study the role of Dectin-1 receptor on cell death induced by Maitake
Pro4X, in vitro cultures of MCF-7 cells were treated for 24 h with β-glucans from
Maitake Pro4X (367 μg/ml) in the presence and absence of Laminarin (200 μg/ml).
The count of living and dead cells was performed in Neubauer’s chamber, using
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Trypan blue exclusion technique. The control group was used as untreated. All the
experiments were performed by triplicate. The results listed in Figure 2 about the
death of MCF-7 tumor cells demonstrated that treatment with Maitake Pro4X
significantly increased (*p < 0.05) the death of tumor MCF-7 cells (from 26,666.67
 103 (2.66  107) in the control untreated to 42,916.67  103 (4.3  107)). A
significant decrease in cell death (*p < 0.05) (26,3750  103 (2.67  107)) was
found when Dectina-1 receptors were blocked with Laminarin (Figure 2).
Figure 1.
β-glucan receptor and laminarin. Upon laminarin binding it is proposed that two Dectin-1 proteins form a
receptor co-motif) of both receptor molecules which is subsequently phosphorylated by SRC. Both phosphorylases
(SYK, spleen tyrosine kinase) trigger downstream events to block the tumoral cell death induced by Maitake
Pro4X. The idea of this graphic was taken from Fesel and Zuccaro [26].
Figure 2.
Effect of tumoral MCF-7 cell death induced by Maitake and dependence of Dectin-1 receptor. In vitro
culture of MCF-7 human tumoral cells was employed to measure the effect of blocking the Dectin-1 receptor
(Laminarin 10ug/ml) in the cell death mechanism induced by Maitake Pro4X (5 mg/ml). The experiment was
performed by triplicate. The results correspond to mean + 2 standard deviations. In the graphic * means p
< 0.05 and n.s means not statistically significant (p > 0.05).
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2.4 Biodistribution of 1,3-beta-glucans from Maitake Pro4X
2.4.1 Biodistribution in oral administration
The uptake of the 1,3-β-glucans from Maitake Pro4X in the various organs was
investigated, as well as their accumulation and passage through the blood–brain
barrier, after oral intake in BALBc mouse. To achieve this goal, two animals of both
sexes were used for each time (n-16), which were administered orally with a single
therapeutic dose of 4 μl of Maitake/mouse dissolved in 8 μl of distilled water,
corresponding to the therapeutic dose of 5 mg of β-glucans/kg. Subsequently, the
mice were treated for 30 min, 1, 2, 4, 7, 16, 24, and 30 h with oral administration
with Maitake Pro4X. After that, animals from all groups were induced to death by
suffocation with CO2 in euthanasia chamber and subsequent cervical dislocation.
During the autopsy, the hepatic, renal, gastrointestinal (duodenum and colon)
organs, lung, and brain removed from each mouse were arranged on a metallic
mesh or cell strainer moistened with cold PBS. By means of gentle circular move-
ments with the plunger of the syringe, the organ was disaggregated in the strainer,
collecting the homogenization in a falcon tube. In the case of gastrointestinal tissue,
its contents were previously removed prior to processing in order to avoid cellular
agglomerations. With Pasteur pipette, three washes of 1 ml each of cold PBS were
performed to facilitate disintegration; the homogenate remained on ice. With 10 ml
syringe and 27 G needle, several passages of aspiration expulsion of tissue filtration
were performed, in order to generate complete homogenization and rupture of any
cell clusters. Subsequently, it was centrifuged at 1000 rpm for 7 min at 4°C, and the
supernatant was discarded. The pellet was resuspended in 4 ml of PBS + SFB 1% and
preserved in the freezer at 80°C for subsequent quantification of the glycoprotein
extract glucans.
Plasma quantification of 1,3-β-glucans was performed after oral administration
of Maitake Pro4X in BALB/c mice. To do time-course curve, two animals were used
for each time (condition), making the slaughter of them at 0.5, 1, 2, 4, 7, 10, 16, 24,
and 34 h. The determination of 1,3-glucans was performed by the colorimetric test
called Glucatell kit (carried out at the Cape Cod Inc. Laboratory, Maryland, USA),
which allowed to obtain curves of plasma concentration (pg/ml) vs. post-
administration time (h) (Figure 3).
Figure 3.
Plasmatic concentration of 1,3 β -glucans vs time of postoral administration. The blood was collected
during the slaughter of BALB/c mice at pre-established times. Plasma determinations of 1,3-b-glucans were
made using the colorimetric method called Glucatell kit. Three peaks of Cpmax were observed following oral
administration of Maitake Pro4X (5 mg/kg).
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The pharmacokinetic parameters that were determined are: area under the curve
(AUC) Cp vs. time), T 1/2 (half-life time), Cp max (maximum plasma concentra-
tion), ke (elimination constant), ka (absorption constant), Ta1/2 (absorption half-
life time), Vd (apparent volume of distribution), and Clt (total systemic clearance).
1.Maximum plasma concentration (Cpmax) and maximum time (Tmax).
The results recorded in Figure 3 suggest that plasma levels of 1,3-glucans
increased rapidly after oral administration, presenting three peaks of
maximum plasma concentration:
a. First peak Cpmax >5000 pg./ml at half an hour after oral administration
of Maitake
b. Second peak Cpmax >5000 pg./ml between 2 and 10 h of oral
administration of Maitake
c. Third peak Cpmax >5000 pg./ml at 34 h of oral administration of
Maitake
After the first peak Cpmax, plasma levels of 1,3-glucans fell sharply, resulting in
a new Cpmax peak between 2 and 10 h. From 10 h., there was a gradual decrease in
the concentration of 1.3-β-glucans. However, after 16 h, a progressive growth of the
concentration of 1,3-β-glucans began again, reaching a third peak Cpmax at 34 h
after oral administration.
2.Elimination speed constant (Ke). The results recorded in Figure 3 suggest
that the removal of 1,3-β-glucans correspond to a first-order kinetic (mono-
compartmental) model. The first Ke1 constant has a 4489/h removal speed and
Ke2 has a speed of 0.236/h. This indicates a high elimination speed for the
range 0.5 to 1 h and more gradual elimination between 10 and 16 h. The first
elimination (Ke1) is 19 times faster than the second (Ke1  19 Ke2).
3.Absorption speed constant (ka). The ka absorption constant was determined
by the residual method, assuming a kinetic model of first order with Ka1 > Ke1.
First, to calculate ka1, it was drawn the Elimination line Log Cp vs. 0.86 to 0.94 h.
Extrapolation was performed to the axis of the ordered, resulting in a line
and 22,011x + 4.8472. The selected absorption Cps corresponded to the times
0.6 h (3850 pg./ml), 0.7 h (2300 pg./ml), and 0.8 h (1350 pg./ml). For each
time, the Log Cp value was determined on the semilogarithmic elimination line
and 22,011x + 4.8472, resulting in 3.53 (0.6 h), 3.31 (0.7 h), and 3.09 (0.8 h).
Applying antilogarithm, the elimination Cp was obtained resulting in
3388.44 pg./ml (0.6 h), 2041.74 pg./ml (0.7 h), and 1230.27 (0.8 h). The
absorption constant ka1 was calculated from the slope of the absorption line
and 29,301x + 44,359, resulting in ka1  6.75/h. It was verified that ka1 > ke1.
The second absorption constant ka2 was determined by the residual method,
assuming a kinetic model of first order with Ka2 > Ke2. The elimination line Log
Cp vs. time was plotted in the interval 13 to 15 h, with its corresponding
extrapolation to the axis of ordered, resulting in the line and  0.1144x + 4.83.
The absorption Cp stakes chosen in the oral administration curve correspond to
the times 1.2 h (1650 pg./ml), 1.4 h (2850 pg./ml), and 1.6 h (3750 pg./ml).
4.Absorption half-life time (Ta1/2). From both ka, the absorption half-life
time (ta1/2) was established. Using the expression t1/2–0.693/ka, the ta1 1/2 
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0.1 h was obtained for ka1, while for ka2, the ta2 1/2  1.9 h. These results
suggest that the plasma concentration of 1,3-glucans that remains to be
absorbed was halved to 0.1 and 1.9 am of oral administration.
5.Elimination half-life time (T1/2). From both Ke, the elimination half-life time
(t1/2) was set, using the expression t1/2–0.693/Ke. For the range 0.5–1 h, t1  2
 0.15 h, while between 10 h to 16 h, t1  2.93 h. The plasma concentration of
1,3-glucans was halved at 0.65 and 12.93 h of oral administration.
6.Distribution volume (Vd). The apparent volume of distribution was
calculated by the expression “Dose/Cp0.” The dose administered to the
animals was 120 mg of β-glucans (4 ml Maitake PRO4X). Cp0 was determined
by extrapolation with the axis of the ordered (ln Cp) in the range 0.5–1 h. So,
for a 20 g mouse, the Vd is 2.55 l/0.02 kg, i.e., Vd is 127 ml/g (127 l/kg), this is a
great value for Vd on the mouse.
7.Clearance total (Clt). Total systemic clearance (Clt) was determined by the
expression Clt -Vd (-Ke). For Ke1, Clt-2,55 l 4489 h-1-11.45 l/h or 190.78 ml/
min), while for Ke2, its Clt is 10.03 ml/min.
8.Area under the curve. The area under the curve Cp vs. time reflects the
amount of bioavailable compound that reaches the systemic circulation and is
capable to produce an effect, as determined by the trapezoidal method,
resulting in 0.118 mg.h/ml for the time interval 0–34 h.
The results shown in Figure 4 about tissue uptake of β-glucans following oral
administration suggest that the highest concentrations occurred in the stomach
(5.52  107 pg.h/ml), duodenum (3.66  107 pg.h/ml), and colon (3.44  107 pg.h/
ml). In addition, we have recorded an important level of uptake in the brain (AUC
of 3.77  104 pg.h/ml) and lung and to a lesser extent at the liver (1.89  104 pg.h/
ml) and renal (2.44  104 pg.h/ml) level. The area under the tissue biodistribution
curve of 1,3-β-glucans for the different organs is indicated in Figure 5. The results
recorded in Figure 5A represents the area under the stomach, duodenum, and colon
uptake curve of β-glucans. The highest hepatic uptake (Figure 5B) occurs at 7 h (*p
< 0.05 vs. 2 h) and the lower at 30 h (with **p < 0.01 vs. 2 h). On the other hand,
Figure 4.
Mouse tissue biodistribution of 1,3-β-glucans. The catches in the various murine organs were compared between
2 and 30 a.m. after 1,3-b-gucans Maitake Pro4X (5 mg/kg) oral administration. The determinations were
made using the colorimetric method of the Glucatell kit. Biodistribution in gastrointestinal organs (stomach,
duodenum, colon) was in the order of millions of pg.h/ml, while in others it was thousands of pg.h/ml.
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liver uptake at 2 h is significantly higher than that which happens at an equal time in
the brain (with *p < 0.05). Also, brain uptake at 30 a.m. is significantly less than
that occurred at the same lung time (with **p < 0.01) (Figure 5B).
2.5 Molecular mechanism of dexamethasone in immunosuppression
In order to induce immunosuppression in the experimental murine model,
dexamethasone was employed, a synthetic glucocorticoid class of steroid hormones
with potent anti-inflammatory and immunosuppressant activities [27].
Dexamethasone-mediated T-cell suppression diminishes naïve T-cell proliferation
and differentiation by attenuating the CD28 co-stimulatory pathway [28]. How-
ever, the exact molecular mechanism induced by dexamethasone in the immuno-
suppression is not yet known. Figure 6 illustrated the possible molecular
mechanism of glucocorticoids (GC) such as dexamethasone on immune cells; GCs
Figure 5
Tissue biodistribution curves of β -glucans. These correspond to the area under the uptake curve of 1,3-
glucans of different murine organs after oral administration of Maitake Pro4X. Mean values +2 standard
deviations of: (A) gastric, colonic, and duodenal uptake in millions of pg./ml. (B) Brain, pulmonary, hepatic,
and renal uptake in thousands of pg./ml. Significant differences were observed (*p < 0.05; **p < 0.01)
between tissue captures and their times.
Figure 6.
Glucocorticoid (GC such as dexamethasone) activity on periphery immune cells. GCs act upon almost every
immune cell type. This figure was modified from Liberman et al. [29].
10
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promote an anti-inflammatory state on both monocytes and macrophages. GCs
prevent monocytes from entering apoptosis and inhibit the liberation of pro-
inflammatory mediators by both types of cells. Particularly in macrophages, GCs
promote phagocytosis and motility, while they inhibit adhesion, apoptosis, and
oxidative burst. They also act upon neutrophil function by inhibiting rolling, adhe-
sion, and activation. GCs act toward dendritic cells by promoting their maturation,
survival, migration, and motility, and at the same time GCs inhibit their ability to
activate T cells by suppressing the production of pro-inflammatory molecules. A
naïve helper T (Th) cell can differentiate into different Th lineages, and GCs exert
different actions. They act upon Th1 by decreasing T-bet transcriptional activity
and suppressing the production of pro-inflammatory molecules such as IL-2 and
IFN-γ. They also suppress GATA3 activity in Th2 cells inhibiting the expression of
IL-4 and IL-5. The action of GCs toward Th17 and regulatory T cells is not yet well
understood [29] (Figure 6).
In order to induce BALBc mouse immunosuppression, 3 g dexamethasone/
mouse was administered daily from the beginning to the end of the experimental
trial, which lasted approximately for 4 weeks. A suspension of glucocorticoid 0.02%
m/v was prepared, for which five tablets of a trademark 0.5 mg were bitten until
completely sprayed and suspended in 12.5 ml of 10% aqueous glucose solution. The
suspension was prepared weekly and kept in a refrigerator until use. From the
suspension of glucocorticoid, daily dainty was administered 15 μl/mouse equivalent
to 3 g/mouse/day (0.15 mg de dexamethasone/kg/day).
2.6 Effect of 1,3-β-glucans in the hematology and white blood cell formula
2.6.1 Blood microscopic analysis
Microscopic peripheral blood spread observations were performed for each of
the experimental conditions. The blood was collected during the autopsy of the
animals and colored with May-Grunwald-Giemsa. Mouse peripheral blood collected
during the autopsy of the animals was transferred to Eppendorf tubes containing
0.5% EDTA, at room temperature. A blood smear was performed, placing a drop of
blood in the center of a clean slide. A thin film of blood was obtained by means of an
object cover (smear). After obtaining the blood smear, it was immediately allowed
to air-dry at room temperature, to proceed to its staining. A few drops of methanol
were added to fix the preparation, and after evaporation of the preparation, the
entire spread was covered with a solution of the May-Grunwald dye for 2–3 min.
Subsequently, and unwashed, the Giemsa dye was added for 20 min. Finally, the
preparation was washed with distilled water by removing the dyes by trawling and
dried at room temperature. Figure 7 shows the following conditions:
2.6.2 Healthy control group
Normal red blood cells, clustered platelets, lymphocytes, neutrophils, and
monocytes were observed (Figure 7 Superior). No immature cells were recorded.
2.6.3 Immunosuppressed group
This group presented in his blood abundant large cells, with prominent nucleus,
and small and vacuolated cytoplasm (compatible with megakaryocytes); other mice
featured megakaryocytes grouped in masse, mastocyte, and PMN basophil and also
exhibited monocytes with well-condensed chromatin and megakaryocytes in
apparent cell division process. Unevenly sized red blood cells (anisocytosis) were
observed (Figure 7 middle).
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2.6.4 Immunosuppressed group treated with Maitake
It exhibited mature blood cells such as lymphocytes and polymorphonuclear
granulocytes (neutrophils and basophils). In addition, some multinucleated giant
cells compatible with megakaryocytes were observed (Figure 7 middle).
2.6.5 Immunosuppressed group treated with Maitake + verapamil
Spiculate red blood cells with hypochromia and/or loss of hemoglobin and signs
of anisocytosis and hemolysis were observed. In addition, megakaryocytes were
released releasing platelets and mastocyte cells in degranulation (Figure 7 bottom).
2.7 Flow cytometry studies: expression of CD19, CD3ε, Ly6G, and CD105
molecular markers in immune cells
Flow cytometry studies were performed to analyze the immune-restorative
ability of Maitake PRO4X’s glucans and recover the immune cell populations with
an antigenic expression of CD3ε, CD19, CD105, or Ly6G. Such studies were
conducted on murine lymphoid tissues (spleen and lymph nodes) removed during
the autopsy of the animals. Maitake’s ability to recover immune cell populations in a
murine model of immunosuppression was investigated. To do this, 29 healthy
BALB/c female mice, 6–8 weeks of age with a weight between 15 and 21 g, were
randomly divided into five groups:
1.Condition 1: Healthy control (n = 8)
2.Condition 2: Immunosuppressed (induced by daily administration of
dexamethasone 0.15 mg/kg) (n = 8)
3.Condition 3: Immunosuppressed withMaitake PRO4X (6 mg of β-glucan/kg/
Day) (n = 8)
Figure 7.
Blood smear of leukocyte formula. The figure shows the microphotographs from the slides (may-Grunwald-
Giemsa x40) indicated in each condition: Healthy control, immunosuppressed in the absence of Maitake Pro4X,
immunosuppressed with Maitake Pro4X, and immunosuppressed in the presence of Maitake Pro4X and
verapamil.
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4.Condition 4: Immunosuppressed withMaitake PRO4X in the presence of a
calcium blockage verapamil (10 mg/kg/Day) (n = 5)
After 30 days of treatment, all animals were sacrificed using CO2 asphyxiation
camera, and the autopsy was performed in all of them. To perform the flow
Figure 8.
Lymphoid cell collection. Mice lymphocytes were obtained from the processing of peripheral lymphoid organs
(spleen and murine lymph nodes (mesenteric, axillary, and inguinal LN). The organs were subjected to
mechanical disintegration to obtain the cell suspension. After that, a pool of immune cells was performed from
each condition studied, cells were stained with specific monoclonal fluorescent anti-mouse antibodies, flow
cytometry was performed by triplicate in a BD Accuri C6, and data were analyzed and interpreted as is
illustrated in the figure.
Figure 9.
Removal of peripheral lymphoid organs. The spleen and lymph nodes (axillary, inguinal, and mesenteric LN)
from the BALB/c mice were removed during the autopsy of the animals and subjected to mechanical disintegration
to obtain immune cells that were subsequently labeled with the specific antibody to perform flow cytometry.
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cytometry studies, immune cells were obtained from peripheral lymphoid organs
(spleen and lymph nodes), which were removed during the autopsy of the mice.
These organs were placed in a strainer, located in the opening of a falcon tube, to
facilitate mechanical disintegration (Figure 8). With the plunger of a syringe,
gentle circular movements were made resulting in tissue disintegration. The
homogenate was collected in the falcon tube. The processing of lymph nodes
involved the removal of the inguinal, mesenteric, and axillary nodules (Figure 9).
Inguinal nodes were observed as small white spots or hardness in the junctions of
the blood vessels, while mesenteric nodules were visualized from the unrolling of
the small intestine, being observed as a chain of small whitish granules located
above the small intestine. From the axillary region, whitish points corresponding to
the axillary nodes were removed (Figure 9). All three types of nodes were placed in
the same strainer after removal, which was previously moistened with cold PBS.
The procedure indicated in Figure 9 allowed to obtain a ganglion homogenate pool,
washed three times with 1 ml of cold PBS, and the homogenate was kept on ice
during the procedure. With 10 ml syringe and 27 G needle, several suction expul-
sion passages of filtration were performed to generate complete homogenization
and smooth any cell cumulus. Subsequently, the homogenate was centrifuged at
1000 rpm for 7 min using a temperature of 4°C; the supernatant was discarded. The
pellet obtained from ganglion cells was resuspended in 4 ml of PBS with bovine fetal
serum (FBS 1%), kept in ice until the time of labeled with fluorescent antibodies for
flow cytometry. Immune cells were count in Neubauer’s chamber before to labeled
with fluorescence. In parallel the same procedure was applied with the spleen tissue.
Different populations of immune cells (T lymphocytes, B lymphocytes, natural
killer cells, stem cells, PMN granulocytes, and macrophages) derived from the
spleen and lymph nodes (Table 3 and Figure 10) were labeled with the following
monoclonal anti-mouse fluorescent antibodies:
• Anti-CD3ε-FITC
• Anti-CD19-PE
The different populations of immune cells (T lymphocytes, B lymphocytes, Natural Killer Cells, Stem cells,
Polymorphonuclear (PMN) granulocytes and macrophages) from splenic and ganglion tissues were labelled with
fluorescent anti-mouse monoclonal antibodies, according to the detail of this table. The conjugated antibody FITC
(Fluorescein isothiocyanate), has excitation and emission spectrum peak wavelengths of approximately 495 nm/519
nm, giving it a green color. PE (phycoerythrin)-conjugate fluorescence has an excitation maximum at 564 nm and an
emission maximum at 574 nm, giving yellow color. Alexa Fluor (AF) conjugated antibody has the longest wavelength
with excitation/emission maximum of 784/814 nm.
Table 3.
Fluorescent anti-mouse antibodies used in flow cytometry.
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• Anti-CD105-AF
• Anti-Ly6G-FITC
The anti-mouse antibodies used in this study recognize specific markers (surface
antigens) of murine immune cells (CD3, CD19, CD105, and Ly6G) and emit fluo-
rescence by being found conjugated with fluorochromes (FITC, PE, and AF), which
have different excitation (excitation) and emission wavelengths (Emission) (see
Table 3). For the fluorescent labeling with the conjugated antibody with PE + FITC,
500 μl of cells from the pellet were taken from the sample pool, and added 150 μl of
PE antibody (1:30) plus 150 μl of FITC antibody (1:30) were mixed and incubated in
dark for 30 min at room temperature. After that time, the cells were washed twice
with 500 μl of cold PBS and centrifuged for 7 min at 1000 rpm. The supernatant was
discarded, the cell pellet was resuspended with 400 μl PBS + PFA (paraformalde-
hyde acid) 1% and kept on ice (always safe from light), until the time of reading on
the cytometer, after homogenization of the samples, and according to the manu-
facturer’s instructions. A BD Accuri C6 flow cytometer was used with a blue laser
(480 nm) for the excitation wavelength and a red laser (640 nm) for the emission
wavelength. The data was acquired on a logarithmic scale and analyzed with the
FlowJo software (Tree Star, Ashland, OR, USA) (Figure 8).
The flow cytometry results of Table 4, Figures 11 and 12 regarding the recovery
of CD3 immune cells suggest that treatment with Maitake Pro4X allows a very
significant recovery (**p < 0.01) of % T/natural killer lymphocytes (from
Figure 10.
Molecular markers in flow cytometry. The immune-restorative effect of Maitake Pro4X in the recovery of
immune cells with antigenic expression of CD3ε, CD19, CD105, and Ly6G of the lymph nodes and splenic
organs, removed after the sacrifice of the mice, was studied.
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6.80  7.08% to 21.09  12.39%) in female BALB/c immunosuppressed with dexa-
methasone with respect to the immunosuppressed control (Figures 11A–C and 12A).
On the other hand, immune-restoration reaches normal values when Maitake
treatment is adjuvant with Verapamil (from 21.09  12.39% to
27.04  29.96%) (Figures 11D and 12A). As for the CD19 labeling, the results of
The percentages obtained by flow cytometry correspond to axillary, mesenteric and inguinal lymph nodes of BALB/c
females treated with Maitake Pro4X in the presence of immunological depletion and/or channel calcium blockage.
The statistically very significant difference are indicated with (**).
Table 4.
Ganglion CD3ε and CD19 expression.
Figure 11.
Expression ganglion CD3/CD19. These correspond to axillary, mesenteric, and inguinal lymph nodes of BALB/
c females of four experimental conditions: (A) healthy control group, (B) immunosuppressed condition, (C)
immunosuppressed group treated with Maitake, (D) immunosuppressed group treated with Maitake +
verapamil.
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Figures 11A–D and 12B suggest that daily dexamethasone depletes the LB/SC
population, while treatment with Maitake Pro4X tends to recover the LB/SC popu-
lation (from 0.00 to 1.10  1.67) (ns, p > 0.05). But this immune-restoration tends
to disappear when treatment involves verapamil (from 1.10  1.67 to 0.00  0.00).
The flow cytometry results indicated in Figure 13A and B regarding the recov-
ery of Ly6G ganglion immune cells suggest that treatment with Maitake Pro4X
significantly increases (with *p < 0.05) the % polymorphonuclear granulocytes
(PMNG) in the immunosuppressed mice with dexamethasone
(immunosuppressed) from 3.88  3.55% to 27.18  9.57%, but does not increase it
in healthy mice group. With respect to the CD105 cells, the results shown in
Figure 13A and C suggest that dexamethasone does not induce depletion of % of
stem cells (SC)/macrophages, given the not that significant differences (ns,
p > 0.05) in the level of these cells among the experimental groups.
Figure 12.
Maitake’s immune-restorative effect on CD3 and CD19 mouse immune ganglion cells. The cytometric
assay was performed on BALB/c females immunosuppressed with dexamethasone. The following are plotted:
(A) CD3ε marking with very significant recovery of LT/NK (**p < 0.01) by Maitake effect in the
immunosuppressed group and (B) CD19 marking with tendency to recover FROM LBT/SC by Maitake effect
(ns, p > 0.05).
Figure 13.
Ly6G/CD105 mouse ganglion expression. (A) Flow cytometry charts correspond to axillary, mesenteric, and
inguinal lymph nodes of BALB/c females of three experimental conditions: Healthy group, immunosuppressed
group alone, and treated with Maitake (B) and (C) Maitake’s immune-restorative effect on Ly6G and CD105
immune ganglion cells. The cytometric assay was performed on BALB/c females immunosuppressed
with dexamethasone. Graphed: (B) shows Ly6G labeling with significant differences in % of PMN granulocytes
(*p < 0.05) and (C) shows the CD105 labeling cells without significant differences in the % of SC (stem cells)/
macrophages cells (ns, p > 0.05).
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2.7.1 Mouse splenic labeling of CD3 and CD19 cells
Flow cytometry results for splenic immune CD3 and CD19 cells’ recovery are
listed in Table 5. This trial was conducted with three experimental conditions:
healthy control, immunosuppressed group alone, and immunosuppressed group
treated with Maitake Pro4X. The flow cytometry results suggest that treatment with
dexamethasone does not induce a significant depletion of the LT/NK population
compared to the other experimental groups (ns, p > 0.05). There is a trend of the
reduction of LT/NK % per share of dexamethasone and a trend of increased LT/NK
by Maitake effect in the immunosuppressed group. Regarding the CD19 labeling
(Table 5), we observe a significant depletion of the splenic population of LB/SC by
dexamethasone (*p < 0.05 vs. healthy group) and a tendency to recover that
population by Maitake (ns, p > 0.05).
As for the immune system, regulating its activation or suppression could con-
tribute to the maintenance of good health. The use of agents that activate host
defense mechanisms (immune-stimulators, immuno-suitors, or biological response
modifiers) could provide an additional therapeutic tool to conventional chemother-
apy [25]. For this reason, many biomedical researches are geared toward the search
for new compounds capable of stimulating an immune response in immunodefi-
cient patients, with pathologies such as HIV/AIDS, cancer, or malnutrition [30, 31].
Numerous immunostimulatory substances have been isolated from plants and
superior fungi, opening the doors for the development of new drugs [30]. This
provides an effective alternative for the treatment of conditions that alter the
normal balance of the body’s immune response [32, 33].
Within this context, we have investigated the immune-restorative capacity of
Maitake Pro4X’s glucans in BALB/c females immunosuppressed with dexamethasone.
In parallel to immunosuppressive treatment, we treat mice with Maitake glycoprotein
extract; it is important to note that no animals perished as a result of immunosup-
pressive treatment and that clinical signs of toxicity or disease were also not observed.
3. Discussion and conclusions
The antitumor and immunosurveillance properties of D-Fraction of Maitake
have been little explored for the application in breast tumor or clinical
The percentages obtained by flow cytometry correspond to murine spleen tissue of BALB/c females treated with
Maitake Pro4X in the presence of immunological depletion with Dexamethasone.
Table 5.
Splenic CD3ε, CD19, Ly6G, and CD105 cell expression.
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immunosuppression pathologies. For this reason, this chapter aims to deepen
research on the pharmacokinetic and pharmacodynamic aspects of β-glucans from
Maitake D-Fraction, as well as their therapeutic effects on immune recovery of
specific lymphocyte populations. This is in order to make a significant contribution
to the development of new preventive and therapeutic strategies to optimize the
pharmacological use of Maitake’s glucans.
As part of our experimental studies, we have observed in physicochemical char-
acterization assays that the pH value of purified Maitake extracts measured at 20°C
(ambient temperature) and 37°C (body temperature) resulted to be acidic with
pH 5.8 for Maitake Pro4X. Moreover, this product was soluble in polar solvents
(water, methanol, ethanol) and insoluble in apolar solvents (n-hexane, ethyl ace-
tate), demonstrating its hydrophilic and polar nature. We also observe an inverse
relationship between the proteoglycan concentration and its solubility in polar
solvents (such as acetone), resulting in insoluble in acetone. The above suggests that
D-Fraction of Maitake has hydrophilic and polar nature. The pH similarity of the
product to the gastrointestinal pH suggests a good absorption at that level, which is
associated with the biodistribution results shown here for oral administration.
The high molecular weight of β-glucans from Maitake extract suggests the great
difficulty of these molecules in crossing biological membranes by simple diffusion,
requiring a specific receptor after entering the systemic circulation, in order to
trigger their molecular action mediated by second intracellular messengers.
Nakashima et al. [34] in agreement with Brown et al. [35, 36] had reported that the
Dectina-1 membrane receptor recognizes “glucans” with links “β-1,3” and/or “β-
1.6” present on the fungal walls, proposing that receptor as a new receptor and as a
therapeutic target for the immunomodulatory effects of glucan compounds.
Another of our in vitro assays showed that the treatment of MCF-7 breast tumor
cells with Maitake + laminarin (Dectin-1 inhibitor) significantly reduced the effect
of cell death triggered by Maitake (p < 0.05). These results suggest a greater
affinity of Dectina-1 receptors with laminarin than Maitake’s glucans. In addition, a
likely laminarin-Dectin-1 complex would prevent the binding of β-glucans to the
tumor receptor by blocking the mechanism that leads to programmed cell death.
As for our pharmacokinetic parameter studies in oral administration, we have
observed three peaks of plasma concentration of 1.3-β-glucans with a maximum peak
that was recorded half an hour after administration (followed by an abrupt decline).
The second peak was recorded between 2 and 10 h thereafter and the last at 34 h after
oral administration of Maitake Pro4X-glucans (5 mg/Kg). The results of our trials
suggest that the plasma removal (clearance) of 1.3-β-glucans corresponds to a first-
order kinetic model (mono-compartmental), obtaining a very rapid first plasma
disappearance initiated at half an hour and a second more gradual elimination at 10 h
later. Hong et al. [37] have reported that orally administered β-1,3-glucans are
transported by macrophages to the spleen, lymph nodes, and bone marrow, implying
a possible plasma reduction of the compound. For our part, we have observed that the
absorption of the compound was higher than the elimination of the compound and
that the volume of the distribution obtained was very high (127 ml/g). These results
would indicate the extensive distribution of glucans in tissues and poor plasma
protein binding. So that probably the 1,3-β-glucans could be found mostly in their
“free” form in blood circulation, being able to diffuse the extravascular compart-
ments, to interact with their receptors, and to trigger a biological response.
Moreover, in the hematological analysis of mouse peripheral blood in various
experimental conditions, we have observed that the dexamethasone
(immunodepleted) group had many giant cells of immature appearance compatible
with megakaryocytes, while the condition with Maitake + dexamethasone group
presented low number of immature cells, in addition to increasing number of
lymphocytes, PMN neutrophils, basophils, and some megakaryocytes. In turn, the
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group dexamethasone + verapamil + Maitake exhibited megakaryocytes and mast
cells in degranulation [38]. The healthy control group did not have immature cells,
with clustered platelets, lymphocytes, neutrophils, and monocytes observed. Our
microscopic observations suggest that as a result of immunodepletion in mice by
dexamethasone, large immature cells are recruited into the bloodstream, while
concomitant treatment with Maitake could contribute to cell maturation, corrobo-
rated by the presence of mature basophil cells, lymphocytes, and polymorphonu-
clear granulocytes. These results suggest that Maitake’s glucans could induce
cellular maturation leading to immune-restoration. However, when treatment with
Maitake involves calcium receptor blockage, its immunosurveillance capacity
would be reduced, highlighting the dependence of extracellular calcium. Estrada
et al. [39] have reported that the “glucans” increase the proliferative capacity of
cultured lymphocytes treated with dexamethasone, reversing the immunosuppres-
sive effect of glucocorticoid, suggesting the ability of the glucans to restore signifi-
cantly specific and non-specific immune parameters in both cell cultures and
animals treated with dexamethasone. For their part, Kotthoff et al. [40] have
reported that antigen-presenting cells generated in the presence of dexamethasone
have reduced the ability to stimulate the proliferation of T cells, while treatment
with β-glucans induces the expression CD69 T-cell maturation markers and pro-
motes Syk and STAT3 phosphorylation, with increased IL-10 secretion, while reduc-
ing the production of IL-12, IL-23, and TNF-A. Masuda et al. [41] reported, in murine
models of tumorigenesis, that MD-Fraction of Grifola frondosa could generate sys-
temic immune response, directly inducing the maturation of dendritic cells through a
Dectin-1 pathway of the receptor Dectin-1 lectin type C. The therapeutic response of
orally administered MD-Fraction was associated with specific T-cell responses of
induced systemic tumor antigen through Dectin-1-dependent activation of dendritic
cells, (ii) increased T-cell infiltration, and (iii) decreased number of immunosup-
pressive cells caused by tumors, such as regulatory T cells and myeloid-derived
suppressive cells [41]. For our part, the studies of flow cytometry in dyed lymph
nodes with CD3ε (LT, NK)/CD19 (LB, SC) suggested that treatment with Maitake
allows a very significant recovery (**p < 0.01) of the T/natural killer lymphocyte
population of immunosuppressed animals with dexamethasone. In turn, concomitant
treatment with verapamil would not affect the described immune-restoration but
would instead contribute to lymphocyte recovery reaching normal values. So
Maitake-induced cellular maturation could be affected by extracellular calcium
blockage based on our microscopic results, but recovery of T/natural killer lympho-
cytes would not be influenced by the ion sequestration. With respect to the LB/SC
population, we note that Maitake Pro4X tended to recover that lymphocyte popula-
tion, but without statistical significance, while joint treatment with verapamil
inhibited this trend. The results described support our hypothesis that extracellular
calcium sequestration affects some of the functionalities of Maitake’s glucans. On
another hand, the molecular marker CD105 (for stem cells/macrophages) was found
no significant differences in the cell population between the different experimental
conditions. Similar results were obtained for ganglion molecular marker CD19 (stem
cells/LB) with no significant differences between animal groups. Regarding Ly6G
ganglion molecular marker (polymorphonuclear granulocytes), we observe that
treatment with Maitake significantly increased the percentage of the cell population
in immunosuppressed mice (*p < 0.05) but not in healthy animals.
Lin et al. [42] in previous studies reported the ability of Maitake’s glucans to
activate the biological response in hematopoiesis, promoting bone marrow recovery
after injury and stimulating activation of the Maitake forming unit granulocyte
and monocyte colonies (GM-CFU), while Kodama et al. [43] have reported that
D-Fraction derived from Grifola frondosa is able to activate immunocompetent cells
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such as macrophages and T cells, with modulation of the balance between T-helper
lymphocytes 1 and 2. Continuing with our studies at the splenic level, we do not
find in the spleen more significant effect of immune-restoration than that described
for lymph nodes, prompting the tendency to recover immune populations by
Maitake effect. In splenic tissue the CD19 (LB/SC) molecular marker labeling was
significantly depleted during treatment with dexamethasone compared to the
healthy group treated with Maitake Pro4X (*p < 0.05), while treatment with
Maitake alone induced only trend in the recovery of B lymphocytes (p > 0.05). In
another sense, dexamethasone did not induce significant depletion of the splenic
CD3 cell population (LT/NK) with respect to the healthy group treated with
Maitake, although it tended to reduce LT/NKs, while concomitant treatment with
Maitake tended to increase this population. Dexamethasone also did not signifi-
cantly deplete the splenic Ly6G cell population (PMN granulocytes) and CD105
(SC/macrophages) for the healthy group treated with Maitake. In the splenic CD105
(SC/macrophages), dexamethasone tended to increase that population compared to
the healthy group treated with Maitake, while joint treatment with Maitake tended
to reduce it. These effects were like those observed for SC/macrophages at the
ganglion level. These results suggest greater relevance of the immune-restorative
effect of Maitake and immunosuppressant effect of dexamethasone at the ganglion
level rather than splenic. Kay and Czop [44] previously reported that dexametha-
sone stimulates monocyte gluconic receptors and promotes phagocytosis by macro-
phages of particles of β-glucans. In vivo studies in murine models of
immunosuppression showed that dexamethasone (immunosuppressant) promotes
the presence of immature immune cells in circulation, while concomitant treatment
with Maitake stimulates maturation and cell differentiation (with the presence of
polymorphonuclear granulocytes, lymphocytes, and basophilic cells). Extracellular
calcium blockage (Maitake + verapamil adjuvant) partially affects the immune-
restorative effect for certain lymphocyte populations. Flow cytometry studies dem-
onstrated a significant immune-restorative effect of Maitake at the ganglion level,
with recovery from polymorphonuclear granulocytes and LT/NK, while concomi-
tant treatment with verapamil further increased the recovery of LT/NK.
In conclusion, the in vivo studies in murine models of immunosuppression
showed that dexamethasone (immunosuppressant) promotes the presence of the
high number of immature immune cells in circulation, while the concomitant treat-
ment with Maitake stimulates maturation and cell differentiation (with the presence
of polymorphonuclear granulocytes, lymphocytes, and basophilic cells). The extra-
cellular calcium blockage (Maitake + verapamil adjuvant) partially affects the
immune-restorative effect for certain lymphocyte populations. Flow cytometry stud-
ies demonstrated a significant immune-restorative effect of Maitake at the ganglion
level, with recovery from polymorphonuclear granulocytes and LT/NK, while con-
comitant treatment with verapamil further increased the recovery of LT/NK.
From the in vivo biodistribution studies in murine models, we have concluded
that after oral administration, there was increased uptake of the gastrointestinal
compound with the predominance of gastric uptake but also important uptake in the
duodenum and colon (in the order of millions of pg.h/ml). The presence of β-glucans
in the brain allows Maitake’s ability to pass through the blood–brain barrier (BHE).
The lower relative uptake recorded at the hepatorenal level allows us to conclude a
lower rate of inactivation and excretion of the compound, evidenced by the longer
circulation time of the compound in the body after a single administration.
In resume, based on the results obtain in this work, we can propose the following
putative molecular mechanism onmice (Figure 14): After oral administration of
1,3-1,6-β-glucans fromMaitake Pro4X, due to its hydrophilic nature and high solubility
in the stomach/duodenumwith similar Ph, the complex 1,3-1,6-β-glucans are captured
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by mastocytes/macrophages through Dectin-1 receptors in M cells in the epithelium
from the small intestine; after that, beta-1,3-glucan fragments (are broken in pieces)
pass through the blood vessels’ endothelium impacting the receptor Dectin-1 on T-
lymphocyte cells, stimulating their expression of lymphokines such as IL-12 and IL-1,
attractingmore T lymphocytes, and helping in the recovery of T-cell population during
immunosuppression. On lymph nodes (ganglion cells), β-1,3-glucan fragments stimu-
lated the stem cells to differentiate into TL andmature to reestablish the TL cells on
blood circulation due to dexamethasone effect on immunosuppression. The most spec-
tacular action of beta-glucans is the effect on PMN granulocytes especially on neutro-
phils (the first barrier of defense in the body) (Figure 14). In conclusion we can be
optimistic to see how promising the beta-1,3-glucan natural compound can be to be
applied in immunodepleted situations helping the T cells and PMN granulocytes
recover its population through stem cell differentiation, maturation, and activation in
order to reestablish a new immune barrier ready to defend the body.
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